Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity ; volume:8 ; number:1 ; day:3 ; month:4 ; year:2018 ; pages:1-11 ; date:12.2018
Scientific reports ; 8, Heft 1 (3.4.2018), 1-11, 12.2018
- Urheber
-
Koizumi, Yukio
- Beteiligte Personen und Organisationen
-
Nagai, Kenichiro
Gao, Lina
Koyota, Souichi
Yamaguchi, Tomokazu
Natsui, Miyuki
Imai, Yumiko
Hasumi, Keiji
Sugiyama, Toshihiro
Kuba, Keiji
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-23745-0
- URN
-
urn:nbn:de:101:1-2018053105512768616795
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koizumi, Yukio
- Nagai, Kenichiro
- Gao, Lina
- Koyota, Souichi
- Yamaguchi, Tomokazu
- Natsui, Miyuki
- Imai, Yumiko
- Hasumi, Keiji
- Sugiyama, Toshihiro
- Kuba, Keiji
- SpringerLink (Online service)
Ähnliche Objekte (12)
Fibrinolytic System and Fibrinolytic Inhibitors in Behcet’s Disease
Fibrinolytische Therapie : = Fibrinolytic therapy
Fibrinolytic System-Heparin Interaction
The Effect of Enhanced Fibrinolytic Activity on the Red Cell Membrane Transport
Laboratory Control of Fibrinolytic Therapy
Human Seminal Plasma Fibrinolytic Activity
Fibrinolytic bacterial enzymes with thrombolytic activity
Furosemide, Fibrinolytic Activity and Urokinase Excretion
Fibrinolytic Activity of Hydatidiform Molar Tissue
Fibrinolytic Activity of Gel Filtered Platelet
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
Fibrinolytic System and Fibrinolytic Inhibitors in Behcet’s Disease
Fibrinolytische Therapie : = Fibrinolytic therapy
Fibrinolytic System-Heparin Interaction
The Effect of Enhanced Fibrinolytic Activity on the Red Cell Membrane Transport
Laboratory Control of Fibrinolytic Therapy
Human Seminal Plasma Fibrinolytic Activity
Fibrinolytic bacterial enzymes with thrombolytic activity
Furosemide, Fibrinolytic Activity and Urokinase Excretion
Fibrinolytic Activity of Hydatidiform Molar Tissue
Fibrinolytic Activity of Gel Filtered Platelet
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
Fibrinolytic System and Fibrinolytic Inhibitors in Behcet’s Disease
Fibrinolytische Therapie : = Fibrinolytic therapy
Fibrinolytic System-Heparin Interaction
The Effect of Enhanced Fibrinolytic Activity on the Red Cell Membrane Transport
Laboratory Control of Fibrinolytic Therapy
Human Seminal Plasma Fibrinolytic Activity
Fibrinolytic bacterial enzymes with thrombolytic activity
Furosemide, Fibrinolytic Activity and Urokinase Excretion
Fibrinolytic Activity of Hydatidiform Molar Tissue
Fibrinolytic Activity of Gel Filtered Platelet
Enhanced cellular therapy: revolutionizing adoptive cellular therapy